Elucidating the exact pharmacological mechanism of action (MOA) of naturally developing compounds is often complicated. Even though Tarselli et al. (60) formulated the very first de novo artificial pathway to conolidine and showcased this naturally taking place compound successfully suppresses responses to both chemically induced and inflammation-derived pain, the https://zbookmarkhub.com/story20995279/details-fiction-and-conolidin-to-replace-traditional-painkillers